Anlon Healthcare

Anlon Healthcare

126.97
+3.18
(2.57%)
hide
Key Fundamentals
Add Ratio
Market Cap
658.00 Cr
EPS
6.37
PE Ratio
32.80
Dividend Yield
0.00 %
Industry
-
52 Week High
147.70
52 Week Low
90.78
PB Ratio
3.34
Debt to Equity
1.46
Sector
-
Forecast For
Actual

Company News

View All News
Caret
neutral
Anlon Healthcare Board Authorizes Commercial Property Purchase in RajkotSep 27, 2025
Anlon Healthcare Limited's Board of Directors authorized the purchase of a commercial office property located at Golden Crown, New 150 Feet Ring Road, Rajkot, Gujarat. The board meeting was held on September 27, 2025, and designated Whole Time Director Meet Atulkumar Vachhani to handle the property acquisition and related procedures. The company trades on BSE under scrip code 544497 and on NSE under scrip code AHCL.
positive
Anlon Healthcare Limited announced the successful development of two new anti-malarial products: Artemether and Lumefantrine. Both products are expected to launch in November 2025. The development is part of the company's strategy to expand its product portfolio and serve evolving client needs. The company will provide further updates on developments to stock exchanges.
neutral
Anlon Healthcare Limited has disclosed a change in shareholding following the acquisition of equity shares in the company. The disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulation, 2011. The company notified both BSE and NSE exchanges about this shareholding change. Anlon Healthcare trades on BSE with scrip code 544497 and on NSE with scrip code AHCL.

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
80.66 %
Net Income Growth
111.34 %
Cash Flow Change
-598.14 %
ROE
-44.45 %
ROCE
43.74 %
EBITDA Margin (Avg.)
15.12 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
2025
TTM
Revenue
16
58
113
67
121
38
Expenses
21
52
101
51
88
31
EBITDA
-5
6
13
16
32
7
Operating Profit %
-33 %
9 %
11 %
23 %
27 %
5 %
Depreciation
2
2
2
2
2
1
Interest
3
4
4
4
4
1
Profit Before Tax
-10
-0
7
10
27
6
Tax
0
0
1
0
6
1
Net Profit
-10
-0
6
10
21
5
EPS in ₹
-8.53
-0.09
4.85
6.68
6.37
2.80

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
71
85
112
128
181
Fixed Assets
29
27
26
27
23
Current Assets
40
58
86
101
159
Capital Work in Progress
0
0
0
0
0
Investments
0
2
4
1
1
Other Assets
43
56
82
100
158
Total Liabilities
71
85
112
128
181
Current Liabilities
31
29
44
50
60
Non Current Liabilities
38
55
61
57
41
Total Equity
2
2
7
21
80
Reserve & Surplus
-10
-10
-5
5
41
Share Capital
12
12
12
16
40

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
-2
1
-1
2
-1
Investing Activities
-3
-0
-0
-3
3
Operating Activities
-15
-2
-3
-3
-23
Financing Activities
16
3
2
8
19

Share Holding

% Holding
Oct 2024
Apr 2025
Jun 2025
Aug 2025
Sept 2025
Promoter
70.26 %
70.26 %
52.68 %
70.26 %
52.68 %
FIIs
0.00 %
0.00 %
14.42 %
0.00 %
14.42 %
DIIs
0.00 %
0.00 %
4.35 %
0.00 %
4.35 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
14.64 %
0.00 %
14.64 %
Others
29.74 %
29.74 %
13.92 %
29.74 %
13.92 %
No of Share Holders
109
131
9,125
135
9,126

Announcements

Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday October 16 20253 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20185 days ago
Board Meeting Intimation for Consider General Business Matter.6 days ago
Closure of Trading WindowSep 29, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 29, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday September 27 2025Sep 27, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 27, 2025
Board Meeting Intimation for Consider And Approve Proposal For Purchase Of Immovable Property.Sep 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 22, 2025
Announcement As Per Regulation 30 Of SEBI LODR Regulations 2015 For Development Of New Product.Sep 20, 2025
Clarification On Price Movement Regarding Letter Received From L/SURV/ONL/PV/AJ/ 2025-2026 / 3092Sep 18, 2025
Clarification sought from Anlon Healthcare LtdSep 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 17, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 15, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 13, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 10, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 09, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 09, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 08, 2025
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 04, 2025
Listing of Equity Shares of Anlon Healthcare LtdSep 03, 2025

Technical Indicators

RSI(14)
Neutral
61.49
ATR(14)
Less Volatile
7.08
STOCH(9,6)
Neutral
41.61
STOCH RSI(14)
Oversold
7.38
MACD(12,26)
Bearish
0.00
ADX(14)
Strong Trend
43.98
UO(9)
Bearish
44.82
ROC(12)
Downtrend And Accelerating
-3.19
WillR(14)
Neutral
-59.94